Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Rydapt

Rydapt 25 mg soft capsules · Abschnitt 4.8 · PDF-Seite 10–11

HOS-135104 · Präparat HOS-097652

10 Eye disorders Eyelid oedema 3.1 0 Common Cardiac disorders Hypotension 14.4 5.5 Very common Sinus tachycardia 9.6 1.2 Common Hypertension 7.9 2.3 Common Pericardial effusion 3.5 0.6 Common Respiratory, thoracic and mediastinal disorders Epistaxis 27.5 2.6 Very common Laryngeal pain 11.8 0.6 Very common Interstitial lung disease/Pneumonitis2 11.4 4.9 Very common Dyspnoea 10.9 5.5 Very common Pleural effusion 5.7 0.9 Common Nasopharyngitis 8.7 0 Common Acute respiratory distress syndrome 2.2 2.3 Common Gastrointestinal disorders Nausea 83.4 5.8 Very common Vomiting 60.7 2.9 Very common Stomatitis 21.8 3.5 Very common Abdominal pain upper 16.6 0 Very common Haemorrhoids 15.3 1.4 Very common Anorectal discomfort 7 0.9 Common Abdominal discomfort 3.5 0 Common Skin and subcutaneous tissue disorders Dermatitis exfoliative 61.6 13.6 Very common Hyperhidrosis 14.4 0 Very common Dry skin 7 0 Common Keratitis 6.6 0.3 Common Acute febrile neutrophilic dermatosis3 - - Not known Musculoskeletal and connective tissue disorders Back pain 21.8 1.4 Very common Arthralgia 14 0.3 Very common Bone pain 9.6 1.4 Common Pain in extremity 9.6 1.4 Common Neck pain 7.9 0.6 Common General disorders and administration site conditions Pyrexia 34.5 3.2 Very common Catheter-related thrombosis 3.5 2 Common

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.